Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
European Journal of Anaesthesiology|September 10, 2010
In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?Thomas Metterlein, Frank Schuster, Peter Kranke, et al.
European Journal of Anaesthesiology|October 8, 2009
Intramuscular injection of malignant hyperthermia trigger agents induces hypermetabolism in susceptible and nonsusceptible individualsThomas Metterlein, Frank Schuster, Peter Kranke, et al.
Muscle & Nerve|May 25, 2011
Succinylcholine in malignant hyperthermia: evaluation of a novel in vivo modelThomas Metterlein, Frank Schuster, Elise Palmer, et al.
Indian Journal of Pharmacology|January 6, 2016
Metabolic effects as a cause of myotoxic effects of fluoroquinolonesThomas Metterlein, Frank Schuster, Martin Hager, et al.
Forensic Science International|June 9, 2009
Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: a designer drug with alpha-pyrrolidinophenone structureFolker Westphal, Thomas Junge, Peter Rösner, et al.
Basic & Clinical Pharmacology & Toxicology|April 21, 2006
Pharmacologic modulation of skeletal muscle metabolism: a microdialysis studyFrank Schuster, Petrus Tas, Rainer Müller, et al.
Expert Opinion on Medical Diagnostics|March 15, 2013
Minimally invasive metabolic testing for malignant hyperthermia susceptibility: a systematic review of the methodology and resultsThomas Metterlein, Frank Schuster, Peter Kranke, et al.
Expert Opinion on Pharmacotherapy|June 4, 2008
Pharmacological interventions and concepts of fast-track perioperative medical care for enhanced recovery programsPeter Kranke, Andreas Redel, Frank Schuster, et al.
Pageof 5